Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE
Report ID | 7392 |
Drug Identification Number | 02408090 |
Brand name | MYLAN-BUPRENORPHINE/NALOXONE |
Common or Proper name | BUPRENORPHINE/NALOXONE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPRENORPHINE NALOXONE |
Strength(s) | 2MG 0.5MG |
Dosage form(s) | TABLET |
Route of administration | SUBLINGUAL |
Packaging size | 100BT |
ATC code | N07BC |
ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-06-26 |
Estimated end date | Unknown |
Actual end date | 2019-09-17 |
Shortage status | Resolved |
Updated date | 2019-09-18 |
Company comments | discontinued in ID 94044. Last lot 3085355 exp 2019-05-31 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v143 | 2019-09-18 | English | Compare |
v142 | 2019-09-17 | French | Compare |
v141 | 2019-09-17 | English | Compare |
v140 | 2018-06-29 | French | Compare |
v139 | 2018-06-29 | English | Compare |
v138 | 2018-06-25 | French | Compare |
v137 | 2018-06-25 | English | Compare |
v136 | 2018-06-09 | English | Compare |
v135 | 2018-05-25 | French | Compare |
v134 | 2018-05-25 | English | Compare |
v133 | 2018-05-18 | French | Compare |
v132 | 2018-05-18 | English | Compare |
v131 | 2018-04-30 | French | Compare |
v130 | 2018-04-30 | English | Compare |
v129 | 2018-04-13 | French | Compare |
v128 | 2018-04-13 | English | Compare |
v127 | 2018-04-13 | English | Compare |
v126 | 2018-03-26 | French | Compare |
v125 | 2018-03-26 | English | Compare |
v124 | 2018-03-25 | English | Compare |